<DOC>
	<DOCNO>NCT01433510</DOCNO>
	<brief_summary>The purpose study assess safety profile specific immunotherapy Grazax three consecutive grass pollen season .</brief_summary>
	<brief_title>Tolerability Grazax Patients With Hayfever Real Life Settings</brief_title>
	<detailed_description>To assess safety profile Grazax accord presence polysensitization and/or asthma enrollment</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<criteria>History grass pollen allergy Positive skin pricktest and/or positive specific IgE grass Severe , unstable uncontrolled asthma ( FEV1 &lt; 70 % predict value )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Allergic</keyword>
	<keyword>Rhinoconjunctivitis</keyword>
	<keyword>Immunotherapy</keyword>
</DOC>